Anthony Caggiano insider trades

Open-market stock purchases and sales by Anthony Caggiano, Chief Medical Officer at Cognition Therapeutics Inc, from SEC Form 4 filings since Nov 1, 2021.

Recent trades

DateStockTradeValue
Apr 16, 2026CGTX Cognition Therapeutics IncBought$11.1K
Feb 15, 2026CGTX Cognition Therapeutics IncSold (not open market)$5.2K
Feb 4, 2026CGTX Cognition Therapeutics IncSold (not open market)$27.7K
Feb 3, 2026CGTX Cognition Therapeutics IncSold (not open market)$12.9K
Feb 3, 2026CGTX Cognition Therapeutics IncBought (not open market)—
Dec 18, 2025CGTX Cognition Therapeutics IncBought (not open market)—
Dec 18, 2025CGTX Cognition Therapeutics IncSold (not open market)$30.4K

Companies traded

  • CGTX Cognition Therapeutics Inc: 1 buy, last Apr 16, 2026

Get free alerts when Anthony Caggiano files a new trade →